Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

VALEANT PHARMACEUTICALS INTL INC T.VRX

"Valeant Pharmaceuticals is a global specialty pharmaceutical firm with a focus on branded products for the dermatology, gastrointestinal, and ophthalmology markets. The firm also has a branded generics business that operates primarily in Latin America, Eastern Europe, and Asia."


TSX:VRX - Post by User

Post by Carlos66on Jul 14, 2016 3:18pm
108 Views
Post# 25053481

people are selling the dips

people are selling the dips
take a look at the chart. The dip yesterday is just one example of overwhelming sell side volume.
---the dip from $90 to $35 in March
---the dip in early June $38. to $30.
---the dip in late June
---the dip in early July

the rise today is less about Pearson saying he still believes in VRX & yet he little skin in the game; and more that Ackman is still in VRX. Heaven help VRX if he leaves.
---also according to the cos. NR...3 drivers coming next week...'Papa indicated its R&D team expects three significant regulatory events next week in respect of brodalumab, latanoprostene bunod and Relistor Oral.'

carlos
<< Previous
Bullboard Posts
Next >>